Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Accumulated Expenses: 2017-2020

Historic Accumulated Expenses for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $4.8 million.

  • Cogent Biosciences' Accumulated Expenses rose 27.32% to $7.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $7.0 million, marking a year-over-year increase of 27.32%. This contributed to the annual value of $4.8 million for FY2020, which is 32.98% down from last year.
  • Latest data reveals that Cogent Biosciences reported Accumulated Expenses of $4.8 million as of FY2020, which was down 32.98% from $7.1 million recorded in FY2019.
  • Cogent Biosciences' Accumulated Expenses' 5-year high stood at $7.1 million during FY2019, with a 5-year trough of $3.0 million in FY2017.
  • Moreover, its 3-year median value for Accumulated Expenses was $5.5 million (2018), whereas its average is $5.8 million.
  • Per our database at Business Quant, Cogent Biosciences' Accumulated Expenses soared by 85.47% in 2018 and then tumbled by 32.98% in 2020.
  • Cogent Biosciences' Accumulated Expenses (Yearly) stood at $3.0 million in 2017, then soared by 85.47% to $5.5 million in 2018, then surged by 30.20% to $7.1 million in 2019, then tumbled by 32.98% to $4.8 million in 2020.